Overcoming Barriers to the Initiation of Insulin Therapy
Author:
Publisher
American Diabetes Association
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://diabetesjournals.org/clinical/article-pdf/25/1/36/320977/0036.pdf
Reference4 articles.
1. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B: Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 29: 1963-1972,2006
2. Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, Landgraf R, Kleinebreil L, the International DAWN Advisory Panel: Resistance to insulin therapy among patients and provides: results of the cross-national Diabetes Attitudes,Wishes and Needs study. Diabetes Care 28: 2673-2679,2005
3. Funnell MM, Kruger DF: Type 2 diabetes: treat to target. Nurse Pract 29: 11-23,2004
4. Funnell MM, Kruger DF: Self-management support for insulin therapy in type 2 diabetes. Diabetes Educ 30:274-280, 2004
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Safety and efficacy of once-weekly basal insulin Fc in people with type 2 diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 study;The Lancet Diabetes & Endocrinology;2023-03
2. Pharmacokinetic and pharmacodynamic properties of the novel basal insulin Fc (insulin efsitora alfa), an insulin fusion protein in development for once‐weekly dosing for the treatment of patients with diabetes;Diabetes, Obesity and Metabolism;2023-01-09
3. Insulin Glargine 300 U/mL Therapy in Children and Adolescents with Type 1 Diabetes;Pediatric Drugs;2022-07-26
4. Initiation and intensification of insulin therapy in type 2 diabetes mellitus: Physician barriers and solutions – An Indian perspective;Endocrine and Metabolic Science;2021-09
5. Practical aspects of usage of insulin in India: Descriptive review and key recommendations;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2021-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3